Cargando…

A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy

Major advances in understanding the pathogenesis of inherited metabolic disease caused by mitochondrial DNA mutations have yet to translate into treatments of proven efficacy. Leber’s hereditary optic neuropathy is the most common mitochondrial DNA disorder causing irreversible blindness in young ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klopstock, Thomas, Yu-Wai-Man, Patrick, Dimitriadis, Konstantinos, Rouleau, Jacinthe, Heck, Suzette, Bailie, Maura, Atawan, Alaa, Chattopadhyay, Sandip, Schubert, Marion, Garip, Aylin, Kernt, Marcus, Petraki, Diana, Rummey, Christian, Leinonen, Mika, Metz, Günther, Griffiths, Philip G., Meier, Thomas, Chinnery, Patrick F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170530/ https://www.ncbi.nlm.nih.gov/pubmed/21788663 http://dx.doi.org/10.1093/brain/awr170

Ejemplares similares

Effects of Idebenone on Color Vision in Patients With Leber Hereditary Optic Neuropathy
por: Rudolph, Guenther, et al.
Publicado: (2013)

Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy
por: Klopstock, T., et al.
Publicado: (2013)

Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy
por: Catarino, Claudia B., et al.
Publicado: (2020)

Gene–environment interactions in Leber hereditary optic neuropathy
por: Kirkman, Matthew Anthony, et al.
Publicado: (2009)

Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2017)

Leber’s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients
por: Dimitriadis, Konstantin, et al.
Publicado: (2014)

Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy
por: Mayer, Oscar H., et al.
Publicado: (2017)

Retinal morphological and functional response to Idebenone therapy in Leber hereditary optic neuropathy
por: Mercuţ, Maria Filofteia, et al.
Publicado: (2022)

Leber’s hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation
por: Tonagel, Felix, et al.
Publicado: (2020)

Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy
por: Buyse, Gunnar M., et al.
Publicado: (2016)

Evaluation of Mitochondrial Dysfunction and Idebenone Responsiveness in Fibroblasts from Leber’s Hereditary Optic Neuropathy (LHON) Subjects
por: Baglivo, Mirko, et al.
Publicado: (2023)

Leber’s Hereditary Optic Neuropathy (LHON): Clinical Experience and Outcomes after Long-Term Idebenone Treatment
por: Baltă, George, et al.
Publicado: (2023)

Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber’s Hereditary Optic Neuropathy
por: Heitz, Fabrice D., et al.
Publicado: (2012)

Case Report: Abnormalities of sperm motility and morphology in a patient with Leber hereditary optic neuropathy: Improvement after idebenone therapy
por: Orssaud, Christophe, et al.
Publicado: (2023)

Changes in Visual Function and Correlations with Inner Retinal Structure in Acute and Chronic Leber’s Hereditary Optic Neuropathy Patients after Treatment with Idebenone
por: Pemp, Berthold, et al.
Publicado: (2021)

Idebenone does not inhibit disability progression in primary progressive MS
por: Kosa, Peter, et al.
Publicado: (2020)

Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I
por: Erb, Michael, et al.
Publicado: (2012)

The effects of idebenone on mitochondrial bioenergetics
por: Giorgio, Valentina, et al.
Publicado: (2012)

Idebenone: When an antioxidant is not an antioxidant
por: Gueven, Nuri, et al.
Publicado: (2020)

The Evaluation of Optic Nerves Using 7 Tesla “Silent” Zero Echo Time Imaging in Patients with Leber’s Hereditary Optic Neuropathy with or without Idebenone Treatment
por: Grochowski, Cezary, et al.
Publicado: (2020)

Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy
por: Sahel, José-Alain, et al.
Publicado: (2021)

Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations
por: Pfeffer, Gerald, et al.
Publicado: (2013)

Variable response to Idebenone in LHON is multifactorial
por: Finsterer, Josef, et al.
Publicado: (2023)

Raised Intraocular Pressure as a Potential Risk Factor for Visual Loss in Leber Hereditary Optic Neuropathy
por: Thouin, Anais, et al.
Publicado: (2013)

Genetic variation in the methylenetetrahydrofolate reductase gene, MTHFR, does not alter the risk of visual failure in Leber’s hereditary optic neuropathy
por: Hudson, Gavin, et al.
Publicado: (2009)

Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy
por: Hudson, Gavin, et al.
Publicado: (2010)

Visual and psychological morbidity among patients with autosomal dominant optic atrophy
por: Bailie, Maura, et al.
Publicado: (2013)

Vitamin B12 in Leber hereditary optic neuropathy mutation carriers: a prospective cohort study
por: Zibold, Julia, et al.
Publicado: (2022)

LHON needs to be genetically diagnosed and the idebenone effect quantified
por: Finsterer, Josef, et al.
Publicado: (2019)

Leber
Publicado: (2011)

Leber
por: Cerwenka, Herwig, et al.
Publicado: (2016)

Stability-Indicating HPLC Assay for Determination of Idebenone in Pharmaceutical Forms
por: Kombath, Sonoube, et al.
Publicado: (2015)

Idebenone Maintains Survival of Mutant Myocilin Cells by Inhibiting Apoptosis
por: Guan, Yue, et al.
Publicado: (2016)

Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy
por: Montenegro, Lucia, et al.
Publicado: (2018)

Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
por: De Gaetano, Federica, et al.
Publicado: (2022)

Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy
por: Reinert, Marie-Christine, et al.
Publicado: (2021)

Developments in the Treatment of Leber Hereditary Optic Neuropathy
por: Chen, Benson S., et al.
Publicado: (2022)

The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy
por: Majander, A., et al.
Publicado: (2017)

In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles
por: Montenegro, Lucia, et al.
Publicado: (2017)

Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study
por: De Gaetano, Federica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t8iioo17mv8i0eakg7ml5a338g